Pharmaline has been acquired by Gilde Healthcare Partners
The private shareholders of Pharmaline have sold 55% of their share capital to Gilde Healthcare Partners for an undisclosed consideration.
Pharmaline is specialized in the semi-industrial manufacturing of unregistered pharmacy preparation products. Pharmaline's facilities and production processes are structured to comply with the guidelines of the Dutch Health Care Inspectorate and the Good Manufacturing Practice guidelines, which have been mandatory for a pharmacy preparation production company since 2007. Pharmaline services the Dutch intramural (hospital pharmacies) and extramural (public pharmacies and general practitioner’s pharmacies) pharmacy markets.
Gilde Healthcare Partners is a European venture capital and growth capital firm. The funds focus on companies engaged in the development of novel therapeutics, diagnostics, medical devices and healthcare services.
Oaklins' team in the Netherlands acted as advisor to the seller in this transaction.
Talk to the deal team
Related deals
Dolmans Landscaping Group has welcomed Foreman Capital as a new shareholder to support further growth
Dolmans Landscaping Group, a leading full-service provider of landscaping services, has welcomed Foreman Capital as a new shareholder. By partnering with Foreman Capital, which has extensive experience in building stronger companies in the maintenance of public spaces, Dolmans can accelerate its growth trajectory across core verticals and further professionalize the business.
Learn moreBackspin has completed a mandatory public tender offer for the shares of Spindox
Backspin S.p.A. has completed a mandatory public tender offer for Spindox S.p.A.
Learn moreRare Patient Voice has been acquired by Konovo
Rare Patient Voice has been acquired by Konovo, a technology-first healthcare intelligence company backed by Fraser Healthcare Partners.
Learn more